indexmarketsresearchFebruary 4, 2021 25
As claimed to the given report,global Percutaneous Coronary Intervention (PCI) Devices market is assessed with
reference to type, application spectrum, and regional countryside.The Market report in its large database titled
Percutaneous Coronary Intervention (PCI) Devices Market. Further, it includes insights provided by the analysts and experts about the financial statements along with the company profiles, products, and services of all the key market players.The report investigates important factors related to the Global Percutaneous Coronary Intervention (PCI) Devices Market that are essential to be understood by new as well as existing players in the given market.The report highlights the important factors such as market share, profitability, sales, production, manufacturing, advertising, technological developments, key market players, regional segmentation and many other significant aspects related to the Global Percutaneous Cor
Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety Profile, With No Clinical Events
January 28, 2021
The DynamX Bioadaptor is a new class of treatment for Coronary Artery Disease.
SINGAPORE, January 28, 2021 /EINPresswire.com/ Elixir Medical’s 24-Month Clinical Results for DynamX Bioadaptor Showed Strong Safety Profile, With No Clinical Events
Elixir Medical, a developer of innovative, drug-eluting cardiovascular devices, announced the 24-month clinical results for the DynamX™ Coronary Bioadaptor System, recently presented at 30th Annual Live Interventions in Vascular Endotherapy conference organised by the National Heart Centre of Singapore (Singapore LIVE). The bioadaptor is the first coronary artery implant that adapts to vessel physiology.
It looks like this was the result of either:
A mistyped address
A broken link on our site
A broken link on a search engine results page
A broken link on someone else s page
Some things to try:
Use the navigation menu at the top Most Read